A student at the Carle Illinois College of Medicine created a lab to provide early hands-on experience with microinvasive ...

Higher mean blood pressure (BP) levels were associated with faster rates of visual field progression in patients with ...

Glaucoma usually happens when extra fluid gradually increases pressure in the eye and causes irreversible damage to the optic ...

EYE Q Optical has continued its commitment to improving ocular health by supporting the Kingston Public Hospital (KPH) in its ...

Glaucoma is a chronic and progressive condition of the eyes, usually caused by damage to the optic nerve, resulting in loss ...

Background/aims To identify whether an intact retinal nerve fibre layer (RNFL) thickness profile could determine the location ...

SpyGlass Pharma Inc. has developed an intraocular lens (IOL) capable of continuously delivering drugs to eyes for up to three ...

People living with diabetes can get one annual eye exam from a Medicare-approved doctor in their state specifically to screen for diabetes-related eye conditions.

According to a new comprehensive report from The Insight Partners, the global Glaucoma Therapeutics Market is experiencing significant growth owing to ...

MediPrint® Ophthalmics (MediPrint), a clinical-stage ophthalmic drug delivery company based in San Diego, announced the results of the Company’s Phase 2b clinical trial of LL-BMT1. Employing a novel ...

Based on this data, artificial intelligence can predict how quickly glaucoma may worsen and suggest a customized treatment plan to prevent vision loss. Artificial intelligence is a powerful tool in ...

Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil ® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients ...